Insider Transactions in Q1 2021 at Ideaya Biosciences, Inc. (IDYA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
Mark Lackner SVP, Head of Biology |
SELL
Open market or private sale
|
Direct |
596
-100.0%
|
$12,516
$21.0 P/Share
|
|
Feb 10
2021
|
Mark Lackner SVP, Head of Biology |
BUY
Exercise of conversion of derivative security
|
Direct |
596
+50.0%
|
$3,576
$6.98 P/Share
|
|
Feb 09
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.82%
|
$100,000
$20.74 P/Share
|
|
Feb 09
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.6%
|
$30,000
$6.92 P/Share
|
|
Feb 09
2021
|
Mark Lackner SVP, Head of Biology |
SELL
Open market or private sale
|
Direct |
1,104
-100.0%
|
$23,184
$21.05 P/Share
|
|
Feb 09
2021
|
Mark Lackner SVP, Head of Biology |
BUY
Exercise of conversion of derivative security
|
Direct |
1,104
+50.0%
|
$6,624
$6.98 P/Share
|
|
Feb 08
2021
|
Mark Lackner SVP, Head of Biology |
SELL
Open market or private sale
|
Direct |
300
-66.67%
|
$6,300
$21.01 P/Share
|
|
Feb 08
2021
|
Mark Lackner SVP, Head of Biology |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+50.0%
|
$1,800
$6.98 P/Share
|
|
Feb 02
2021
|
Bvf Partners L P |
SELL
Open market or private sale
|
Direct |
46,409
-1.58%
|
$835,362
$18.0 P/Share
|
|
Jan 26
2021
|
Mark Lackner SVP, Head of Biology |
SELL
Open market or private sale
|
Direct |
2,501
-84.01%
|
$45,018
$18.55 P/Share
|
|
Jan 26
2021
|
Mark Lackner SVP, Head of Biology |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+26.23%
|
$7,500
$5.8 P/Share
|